A pilot study for the effects of donepezil therapy on cerebral and optic nerve head blood flow, visual field defect in normal-tension glaucoma

Journal of Ocular Pharmacology and Therapeutics

Volumn 26, Issue 2, 2010, Pages 187-192

  Yoshida, Yukiko ^a   Sugiyama, Tetsuya ^b   Utsunomiya, Keita ^c   Ogura, Yasuharu ^b   Ikeda, Tsunehiko ^b  

^a Ujigawa Hospital   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; IOFETAMINE I 123; LATANOPROST; TIMOLOL;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MALE; OPTIC NERVE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VISUAL FIELD; VISUAL FIELD DEFECT;

ADMINISTRATION, ORAL; AGED; BLOOD FLOW VELOCITY; BRAIN; CEREBROVASCULAR CIRCULATION; CHOLINESTERASE INHIBITORS; FEMALE; HUMANS; INDANS; INTRAOCULAR PRESSURE; IOFETAMINE; LASER-DOPPLER FLOWMETRY; LOW TENSION GLAUCOMA; MALE; OPTIC DISK; PILOT PROJECTS; PIPERIDINES; RADIOPHARMACEUTICALS; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VISION DISORDERS; VISUAL FIELDS;

EID: 77951686985     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2009.0117     Document Type: Article

References (30)

1. Quigley, H. A., Nickells, R. W., Kerrigan, L. A., et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest. Ophthalmol. Vis. Sci. 36: 774-786, 1995.
2. Bayer, A. U., Ferrari, F., and Erb, C. High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur. Neurol. 47: 165-168, 2002. (Pubitemid 34253039)
3. Tamura, H., Kawakami, H., Kanamoto, T., et al. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J. Neurol. Sci. 246: 79-83, 2006. (Pubitemid 43815345)
4. Tatton, W., Chen, D., Chalmers-Redman, R., et al (Pubitemid 41126693)
5. Miki, A., Otori, Y., Morimoto, T., et al. Protective effect of donepezil on retinal ganglion cells in vitro and in vivo. Curr. Eye Res. 31: 69-77, 2006. (Pubitemid 43155546)
6. Sugiyama, T., Utsunomiya, K., Ota, H., et al. Comparative study of cerebral blood fl ow in patients with normal-tension glaucoma and control subjects. Am. J. Ophthalmol. 141: 394-396, 2006. (Pubitemid 43188054)
7. Iida, H., Itoh, H., Nakazawa, M., et al. Quantitative mapping of regional cerebral blood fl ow using iodine-123-IMP and SPECT. J. Nucl. Med. 35: 2019-2030, 1994. (Pubitemid 24376622)
8. Kogure, D., Matsuda, H., Ohnishi, T., et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J. Nucl. Med. 41: 1155-1162, 2000. (Pubitemid 30463997)
9. Matsuda, H. Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT. J. Nucl. Med. 48: 1289-1300, 2007. (Pubitemid 47242794)
10. Waragai, M., Mizumura, S., Yamada, T., et al. Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy Z-score imaging system analysis. Dement. Geriatr. Cogn. Disord. 26: 547-555, 2008.
11. Sugiyama, T., Araie, M., Riva, C. E., et al. Use of laser speckle fl owgraphy in ocular blood fl ow research. Acta Ophthalmol. 2009. [Epub ahead of print] 12.
12. Sugiyama, T., Koj ima, S., Ishida, O., et al. Changes in optic nerve head blood fl ow induced by the combined therapy of latanoprost and beta-blockers. Acta Ophthalmol 87: 797-800, 2009.
13. Winblad, B., Engedal, K., Soininen, H., et al.; Donepezil Nordic Study Group. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology. 57: 489-495, 2001. (Pubitemid 32757598)
14. Blesa, R. Noncognitive symptoms and long-term treatment expectations for Alzheimer disease. Alzheimer Dis. Assoc. Disord. 18 (Suppl 1): S9-16, 2004. (Pubitemid 38737788)
15. Johannsen, P (Pubitemid 39410100)
16. Courtney, C., Farrell, D., Gray, R., et al.; AD2000 Collaborative Group. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet. 363: 2105-2115, 2004.
17. Winblad, B., Wimo, A., Engedal, K., et al. 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy. Dement. Geriatr. Cogn. Disord. 21: 353-363, 2006. (Pubitemid 43735680)
18. Seltzer, B. Is long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justifi ed? Drugs Aging. 24: 881-890, 2007. (Pubitemid 350085750)
19. Wallin, A. K., Andreasen, N., Eriksson, S., et al.; Swedish Alzheimer Treatment Study Group. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting. Dement. Geriatr. Cogn. Disord. 23: 150-160, 2007. (Pubitemid 46333782)
20. Takada, Y., Yonezawa, A., Kume, T., et al. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. J. Pharmacol. Exp. Ther. 306: 772-777, 2003. (Pubitemid 36886179)
21. Akasofu, S., Kimura, M., Kosasa, T., et al. Protective effect of donepezil in primary-cultured rat cortical neurons exposed to N-methyl-d-aspartate (NMDA) toxicity. Eur. J. Pharmacol. 530: 215-222, 2006. (Pubitemid 43075491)
22. Guo, L., Salt, T. E., Luong, V., et al. Targeting amyloid-beta in glaucoma treatment. Proc. Natl. Acad. Sci. USA. 104: 13444-13449, 2007.
23. Arias, E., Gallego-Sandín, S., Villarroya, M., et al. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. J. Pharmacol. Exp. Ther. 315: 1346-1353, 2005. (Pubitemid 41635424)
24. Nobili, F., Vitali, P., Canfora, M., et al. Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients. Clin. Neurophysiol. 113: 1241-1248, 2002. (Pubitemid 34874515)
25. Rodriguez, G., Vitali, P., Canfora, M., et al. Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease. Clin. Neurophysiol. 115: 39-49, 2004. (Pubitemid 38045593)
26. Sato, A., and Sato, Y. Cholinergic neural regulation of regional cerebral blood fl ow. Alzheimer Dis. Assoc. Disord. 9: 28-38, 1995.
27. Magistretti, P. J. Brain energy metabolism. In: Zigmond, M. J., eds. Fundamental Neuroscience. New York: Academic Press; 1999; p. 389-413.
28. Yoshitomi, T., Ishikawa, H., and Hayashi, E. Pharmacological effects of pilocarpine on rabbit ciliary artery. Curr. Eye Res. 20: 254-259, 2000. (Pubitemid 30428154)
29. Koseki, N., Araie, M., Tomidokoro, A., et al A Placebo-controlled 3-year Study of A Calcium Blocker on Visual Fi Eld and Ocular Circulation in Glaucoma with Low-normal Pressure. Ophthalmology. 115: 2049-2057, 2008.
30. Narimatsu, N., Harada, N., Kurihara, H., et al. Donepezil improves cognitive function in mice by increasing the production of insulin-like growth factor-I in the hippocampus. J. Pharmacol. Exp. Ther. 330: 2-12, 2009.